Logo image of NDRA

ENDRA LIFE SCIENCES INC (NDRA) Stock Price, Quote, News and Overview

NASDAQ:NDRA - Nasdaq - US29273B5003 - Common Stock - Currency: USD

3.98  +0.53 (+15.36%)

After market: 3.9 -0.08 (-2.01%)

NDRA Quote, Performance and Key Statistics

ENDRA LIFE SCIENCES INC

NASDAQ:NDRA (4/25/2025, 8:26:20 PM)

After market: 3.9 -0.08 (-2.01%)

3.98

+0.53 (+15.36%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High664.83
52 Week Low2.97
Market Cap2.23M
Shares560.00K
Float560.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-12 2025-05-12
IPO06-28 2017-06-28


NDRA short term performance overview.The bars show the price performance of NDRA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

NDRA long term performance overview.The bars show the price performance of NDRA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NDRA is 3.98 USD. In the past month the price decreased by -6.35%. In the past year, price decreased by -99.1%.

ENDRA LIFE SCIENCES INC / NDRA Daily stock chart

NDRA Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.96 223.47B
ISRG INTUITIVE SURGICAL INC 67.35 184.36B
BSX BOSTON SCIENTIFIC CORP 37.74 150.72B
SYK STRYKER CORP 29.95 139.34B
MDT MEDTRONIC PLC 15.76 107.94B
BDX BECTON DICKINSON AND CO 14.74 58.89B
EW EDWARDS LIFESCIENCES CORP 29.25 44.70B
IDXX IDEXX LABORATORIES INC 38.88 35.45B
RMD RESMED INC 25.98 34.64B
GEHC GE HEALTHCARE TECHNOLOGY 15.24 31.33B
DXCM DEXCOM INC 43.43 28.10B
PHG KONINKLIJKE PHILIPS NVR- NY 15.84 23.53B

About NDRA

Company Profile

NDRA logo image ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. The firm's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. The company is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Company Info

ENDRA LIFE SCIENCES INC

3600 Green Ct Ste 350

Ann Arbor MICHIGAN 48105 US

CEO: Francois Michelon

Employees: 21

Company Website: https://www.endrainc.com/

Investor Relations: http://investors.endrainc.com/

Phone: 17343350468

ENDRA LIFE SCIENCES INC / NDRA FAQ

What is the stock price of ENDRA LIFE SCIENCES INC today?

The current stock price of NDRA is 3.98 USD. The price increased by 15.36% in the last trading session.


What is the ticker symbol for ENDRA LIFE SCIENCES INC stock?

The exchange symbol of ENDRA LIFE SCIENCES INC is NDRA and it is listed on the Nasdaq exchange.


On which exchange is NDRA stock listed?

NDRA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ENDRA LIFE SCIENCES INC stock?

7 analysts have analysed NDRA and the average price target is 76.5 USD. This implies a price increase of 1822.11% is expected in the next year compared to the current price of 3.98. Check the ENDRA LIFE SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ENDRA LIFE SCIENCES INC worth?

ENDRA LIFE SCIENCES INC (NDRA) has a market capitalization of 2.23M USD. This makes NDRA a Nano Cap stock.


How many employees does ENDRA LIFE SCIENCES INC have?

ENDRA LIFE SCIENCES INC (NDRA) currently has 21 employees.


What are the support and resistance levels for ENDRA LIFE SCIENCES INC (NDRA) stock?

ENDRA LIFE SCIENCES INC (NDRA) has a support level at 3.51 and a resistance level at 3.99. Check the full technical report for a detailed analysis of NDRA support and resistance levels.


Should I buy ENDRA LIFE SCIENCES INC (NDRA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ENDRA LIFE SCIENCES INC (NDRA) stock pay dividends?

NDRA does not pay a dividend.


When does ENDRA LIFE SCIENCES INC (NDRA) report earnings?

ENDRA LIFE SCIENCES INC (NDRA) will report earnings on 2025-05-12.


What is the Price/Earnings (PE) ratio of ENDRA LIFE SCIENCES INC (NDRA)?

ENDRA LIFE SCIENCES INC (NDRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-90.5).


What is the Short Interest ratio of ENDRA LIFE SCIENCES INC (NDRA) stock?

The outstanding short interest for ENDRA LIFE SCIENCES INC (NDRA) is 5.64% of its float. Check the ownership tab for more information on the NDRA short interest.


NDRA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NDRA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NDRA. No worries on liquidiy or solvency for NDRA as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NDRA Financial Highlights

Over the last trailing twelve months NDRA reported a non-GAAP Earnings per Share(EPS) of -90.5. The EPS increased by 60.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -258.47%
ROE -449.46%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%97.42%
Sales Q2Q%N/A
EPS 1Y (TTM)60.31%
Revenue 1Y (TTM)N/A

NDRA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NDRA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners0.02%
Ins Owners0.02%
Short Float %5.64%
Short Ratio0.21
Analysts
Analysts82.86
Price Target76.5 (1822.11%)
EPS Next Y46.51%
Revenue Next YearN/A